Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

1. What is the purpose of the ARCHIE study?

The ARCHIE study will find out whether giving an antibiotic called co-amoxiclav to children aged 6 months to 12 years with a long term condition (‘at risk’) early on when they have flu or flu-like illness might:

  • Help prevent  them developing secondary bacterial infections
  • Help them get better more quickly
  • Affect how well antibiotics work against similar infections in future.